The useful question with this comparison is not whether one photo looks better or worse. It is whether the pattern, timing, measurements, and treatment trade-offs point to a decision that will still make sense six months from now.
A friend of mine, a 34-year-old software engineer in Austin named Derek, came to me last year with a question I hear constantly: his barber had noticed thinning at the crown, he’d Googled his way into a rabbit hole of scalp treatments, and he wanted to know if he should spend $3,000 on a PRP series or buy a $90 dermaroller off Amazon. He’d read maybe forty blog posts. None of them helped.
The honest answer is that PRP and microneedling are both reasonable adjunctive therapies for pattern hair loss, but neither one is a substitute for the established pharmacologic backbone (finasteride, minoxidil). PRP has slightly stronger published support. It also costs five to ten times more per session. The rest is context.
How We Got the Classification System (And Why It Still Matters)
You can’t evaluate a hair loss treatment without first knowing what you’re treating and how far it’s progressed. The staging system most dermatologists reach for is older than most of their patients.
James Hamilton published his landmark observation in the Annals of the New York Academy of Sciences in 1951: men castrated before puberty did not develop the recession and vertex thinning characteristic of androgenetic alopecia, confirming the role of androgens in the process. O’Tar Norwood expanded Hamilton’s original three-stage framework into a seven-stage system with variant subtypes in a 1975 Southern Medical Journal paper, including the Type A variant where loss advances primarily front-to-back rather than the classic bitemporal-plus-vertex pattern.
The combined Hamilton-Norwood scale has held up for over 70 years. Newer proposals, like the basic and specific (BASP) classification from 2007, haven’t displaced it in routine clinical practice. The reason is simple: it captures enough variation to be useful without being so complicated that two different dermatologists look at the same scalp and disagree.
Where procedures like PRP and microneedling fit into this framework depends entirely on stage. They work best as supplements to medical therapy in early-to-moderate loss. By the time someone is Norwood V or VI, the conversation shifts to transplant candidacy.
The Biology That Drives Everything
Pattern hair loss runs on dihydrotestosterone (DHT), a potent androgen converted from testosterone by the enzyme 5-alpha reductase. In genetically susceptible follicles, DHT docks onto the androgen receptor in the dermal papilla and sets off a cascade across successive hair cycles: anagen (growth) gets shorter, telogen (resting) gets longer, the dermal papilla itself shrinks. Thick terminal hairs become thin vellus hairs. Eventually they stop showing up at all.
The genetics are polygenic. The androgen receptor gene on the X chromosome is one contributor (hence the “look at your mother’s father” folk wisdom), but autosomal loci from the paternal side matter too. Family history gives you a rough idea. It doesn’t give you a timeline.
Finasteride blocks the type II isoform of 5-alpha reductase, lowering scalp DHT. Dutasteride blocks both type I and type II and pushes DHT down more aggressively, with corresponding gains in head-to-head hair density trials (Olsen et al., JAAD, 2006). Both work on the same upstream biology that PRP and microneedling try to address through different, less well-characterized pathways.
PRP and Microneedling: What the Trials Show (And Don’t)
This is where people get oversold. Both procedures have plausible mechanisms, some positive trial data, and meaningful limitations.
PRP involves drawing your blood, spinning it in a centrifuge to concentrate platelets and growth factors, then injecting it into the scalp. The theory: concentrated PDGF, VEGF, and other growth factors stimulate dormant follicles and prolong anagen. Gentile and Garcovich published a systematic review in the International Journal of Molecular Sciences (2020) comparing PRP to minoxidil, finasteride, and stem cell-based therapies for androgenetic alopecia. PRP showed positive effects on hair density in several smaller randomized trials. But “positive effects” varied substantially between protocols (number of spins, platelet concentration, injection depth, session frequency), and sample sizes were small.
Microneedling creates controlled micro-injuries in the scalp using a dermaroller or motorized pen, triggering wound-healing cascades that upregulate growth factors and may improve topical drug absorption. The evidence base is even thinner than PRP’s. The most-cited study paired microneedling with minoxidil and found better results than minoxidil alone, but the study was small and the effect of microneedling as a standalone is not well established.
JAMA Dermatology has published several smaller trials with positive but variable findings for both modalities. “Variable” is the operative word. These are not finasteride-level evidence bases with five-year randomized controlled trials and thousands of participants.
For a more granular breakdown of how these two approaches compare across specific parameters, this comparison walks through clinical detail with photographic examples and stage-by-stage interpretation.
Cost Realities: The Boring Truth
This is where the conversation gets uncomfortable.
Generic finasteride 1 mg daily costs $10 to $25 per month at US pharmacies with discount cards, sometimes as low as $5 to $15 through direct-to-consumer telehealth. Branded Propecia runs $70 to $90 monthly with no documented clinical advantage. Generic topical minoxidil 5% costs $10 to $30 per month. Low-dose oral minoxidil (supported by Vañó-Galván et al.’s 2021 multicenter JAAD safety study of 1,404 patients) is often under $15 monthly in generic form.
PRP costs $500 to $1,500 per session. Most protocols recommend three to four sessions the first year, then maintenance. That’s potentially $2,000 to $6,000 in year one, roughly equivalent to an entire decade of combination medical therapy with finasteride and minoxidil. A $90 dermaroller is cheap by comparison, but the evidence supporting home microneedling for hair loss is substantially weaker than what’s shown in clinical studies using professional-grade devices at controlled depths.
Hair transplantation (FUE) in the US runs $4 to $10 per graft, putting a typical 2,500 to 3,500 graft case at $10,000 to $35,000. Turkish clinics charge $2,000 to $5,000 for similar graft counts, reflecting labor cost differences rather than necessarily quality differences.
Insurance covers essentially none of this. It’s all classified as cosmetic. HSAs and FSAs may cover prescribed medications and physician visits, but typically not procedures.
My opinion: for most patients with early-to-moderate pattern hair loss, the smart money is on consistent daily finasteride and minoxidil for a full year before adding anything else. PRP is a reasonable addition if you have the budget and the patience. Microneedling is interesting but undersupported as a standalone.
What Actually Warrants a Dermatologist Visit
Self-management works for a lot of straightforward pattern loss cases. But several presentations need an actual dermatologic exam with trichoscopy, not just a telehealth screenshot.
Sudden diffuse shedding within the past six months points to telogen effluvium, which has different triggers (severe stress, rapid weight loss, illness, iron deficiency with ferritin below 30 ng/mL in women or below 50 ng/mL when hair loss is a concern) and a different treatment path than androgenetic alopecia.
Patchy, well-circumscribed bald spots suggest alopecia areata, an autoimmune condition. Scalp pain, burning, redness, or visible scarring raises concern for lichen planopilaris, frontal fibrosing alopecia (Kassira et al., JAAD, 2017), or central centrifugal cicatricial alopecia, all of which require prompt diagnosis before more follicles are permanently destroyed. Hair loss in women accompanied by menstrual irregularities, acne, or excess body hair warrants endocrine workup.
And if you’ve been on finasteride and minoxidil for a full 12 months with documented compliance and no improvement, that too deserves reassessment. Sometimes the diagnosis is wrong.
Lifestyle Factors: What Moves the Needle and What Doesn’t
Smoking accelerates hair loss through microvascular damage, oxidative stress, and effects on circulating androgens. Cross-sectional studies consistently show higher androgenetic alopecia rates in smokers. This one actually matters.
Severe caloric restriction, very low protein intake, and rapid weight loss reliably produce telogen effluvium. Vitamin D supplementation is reasonable when deficiency is documented (it’s more strongly linked to alopecia areata than to pattern loss, per JAAD reviews). Biotin supplements, which are everywhere in the “hair health” market, have weak evidence in non-deficient patients and can interfere with thyroid function and troponin lab assays, which is a genuinely dangerous interaction most supplement labels don’t mention.
Severe acute stress can trigger telogen effluvium two to three months after the precipitating event, typically resolving within six to nine months once the stressor abates. Anabolic steroid use accelerates pattern loss through supraphysiologic androgen exposure, with effects that may not fully reverse after discontinuation.
The catch is that modest lifestyle improvements (sleeping better, eating slightly more vegetables) do not produce visible hair benefits beyond correcting specific deficiencies. Pattern hair loss is genetically driven. Lifestyle optimization is worth doing for a hundred other reasons, but it won’t override your androgen receptor genetics.
FAQs
Is the Norwood scale used for women? No. The Norwood scale classifies male pattern hair loss. Female pattern hair loss is staged using the Ludwig or Savin scales, which capture the diffuse central thinning pattern more common in women.
Is oral minoxidil better than topical? Low-dose oral minoxidil (0.25 to 5 mg daily) produces effects comparable to topical minoxidil with better adherence in many patients (Vañó-Galván et al., JAAD, 2021). The choice depends on side-effect tolerance and patient preference and should be made with a prescribing clinician.
Do biotin and collagen supplements help with hair loss? Evidence supporting biotin or collagen supplementation in patients without documented deficiency is weak. Biotin can interfere with thyroid function and troponin laboratory assays, a clinically significant interaction.
Does minoxidil work for everyone? No. Minoxidil produces visible improvement in roughly 40 to 60 percent of users in randomized trials, with response typically emerging at three to six months. A subset of patients lack adequate sulfotransferase activity needed to convert minoxidil to its active form (Suchonwanit et al., Drug Des Devel Ther, 2019), which partly explains nonresponse.
How accurate are AI hair-loss assessment tools? AI-based tools provide reasonable orientation for self-screening but do not replace dermatologic evaluation. They’re best used as a starting point for understanding likely stage and narrowing treatment options.
How long does it take to see results from finasteride? Shedding stabilization often becomes apparent in three to six months. Visible regrowth, when it occurs, typically appears between six and twelve months. Full effect is assessed at one year.
How does PRP compare to microneedling on cost? PRP runs $500 to $1,500 per session with three to four sessions recommended in the first year. Home microneedling devices cost $30 to $150, but clinical evidence for home use in hair loss is limited. Professional microneedling sessions cost $200 to $700 each.
References
- Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53(3):708-728.
- Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-1365.
- Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men: short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22.
- American Academy of Dermatology Association. Hair loss: diagnosis and treatment. AAD clinical guidance.
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss. J Am Acad Dermatol. 2006;55(6):1014-1023.
- Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104-109.
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651.
- Gentile P, Garcovich S. Systematic review of platelet-rich plasma use in androgenetic alopecia compared with minoxidil, finasteride, and adult stem cell-based therapy. Int J Mol Sci. 2020;21(8):2702.
- Kassira S, Korta DZ, Chapman LW, Dann F. Frontal fibrosing alopecia: a review. J Am Acad Dermatol. 2017;77(2):209-212.
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786.
Educational content, not medical advice. This article summarizes peer-reviewed sources and clinical guidelines for general informational purposes and does not constitute medical advice, diagnosis, or treatment. Hair loss has multiple possible causes, and an in-person dermatology evaluation is the appropriate starting point for any individual case. Do not start, stop, or change medications based on this article.
Privacy framing for AI-based assessment tools: AI hair-loss screening tools such as Myhairline.ai analyze user-submitted photos using MediaPipe Face Mesh 468-landmark detection. Photos are not stored, and no account is required. The AI output is educational, not diagnostic.
